Skip to main content
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2007 Jul;68(4):242–248. doi: 10.1016/j.curtheres.2007.08.007

Comparison of the Antibacterial Activity of Lidocaine 1% Versus Alkalinized Lidocaine In Vitro

Zekine Begec 1,*, Nurcin Gulhas 1, H Ilksen Toprak 1, Gulay Yetkin 2, Cigdem Kuzucu 2, M Ozcan Ersoy 1
PMCID: PMC3967346  PMID: 24683214

Abstract

Background: Infections after epidural and spinal blocks are rare. The topical anesthetic liclocaine used in these procedures has been found to have antibacterial effects on various microorganisms.

Objective: The aim of this study was to assess the antibacterial effects of alkalinized liclocaine on Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.

Methods: Lidocaine 2%, alkalinized lidocaine, and physiologic saline (as a control solution) were added to standard bacterial preparations. The final concentration of the lidocaine was 10 mg/mL (1%). At baseline and 3 and 6 hours after incubation at 37°C, 3-mL aliquots were vortexed and pipetted into sterile polystyrene spectrophotometer cuvettes. Baseline referred to the end of the period of preparation of the solution (≤20 minutes). Growth was measured as the optical density at a wavelength of 540 nm.

Results: Compared with the control, lidocaine significantly inhibited the growth of S aureus, E coli, and P aeruginosa at baseline and 3 and 6 hours after incubation (all, P < 0.05). Alkalinized lidocaine significantly inhibited the growth of S aureus at baseline and 3 and 6 hours (all, P < 0.05), while it significantly inhibited the growth of E coli and P aeruginosa only at 6 hours (both, P < 0.05). The growth of E coli was significantly less in lidocaine than in alkalinized lidocaine at 0 and 3 hours (both, P < 0.05).

Conclusion: The antibacterial effect of lidocaine 1% on S aureus was not changed after alkalinization. The effect of alkalinized lidocaine on E coli and P aeruginosa was significant only at 6 hours. Lidocaine significantly inhibited the growth of these 3 microorganisms at all study periods.

Key words: lidocaine, alkalinization, sodium bicarbonate, microbiologic phenomena

Full Text

The Full Text of this article is available as a PDF (432.4 KB).

References

  • 1.Batai I, Kerenyi M, Falvai J, Szabo G. Bacterial growth in ropivacaine hydrochloride. Anesth Analg. 2002;94:729–731. doi: 10.1097/00000539-200203000-00046. [DOI] [PubMed] [Google Scholar]
  • 2.Aydin ON, Eyigor M, Aydin N. Antimicrobial activity of ropivacaine and other local anaesthetics. Eur J Anaesthesiol. 2001;18:687–694. doi: 10.1046/j.1365-2346.2001.00900.x. [DOI] [PubMed] [Google Scholar]
  • 3.Pete P, Lindgren L, Vaara M. Poor antibacterial effect of ropivacaine: Comparison with bupivacaine. Anesthesiology. 1999;91:884–886. doi: 10.1097/00000542-199909000-00047. [DOI] [PubMed] [Google Scholar]
  • 4.Ohsuka S, Ohta M, Masuda K. Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways. Microbiol Immunol. 1994;38:429–434. doi: 10.1111/j.1348-0421.1994.tb01803.x. [DOI] [PubMed] [Google Scholar]
  • 5.Schmidt RM, Rosenkranz HS. Antimicrobial activity of topical anesthetics: Lidocaine and procaine. J Infect Dis. 1970;121:597–607. doi: 10.1093/infdis/121.6.597. [DOI] [PubMed] [Google Scholar]
  • 6.Hlavin ML, Kaminski HJ, Ross JS, Ganz E. Spinal epidural abscess: A ten-year perspective. Neurosurgery. 1990;27:177–184. [PubMed] [Google Scholar]
  • 7.Sakuragi T, Ishino H, Dan K. Bactericidal activity of clinically used local anesthetics on Staphylococcus aureus. Reg Anesth. 1996;21:239–242. [PubMed] [Google Scholar]
  • 8.Moore DC. The pH of local anesthetic solutions. Anesth Analg. 1981;60:833–834. [PubMed] [Google Scholar]
  • 9.Ramos G, Pereira E, Simonetti MP. Does alkalinization of 0.75% ropivacaine promote a lumbar peridural block of higher quality? Reg Anesth Pain Med. 2001;26:357–362. doi: 10.1053/rapm.2001.24257. [DOI] [PubMed] [Google Scholar]
  • 10.Curatolo M, Petersen-Felix S, Arendt-Nielsen L. Adding sodium bicarbonate to lidocaine enhances the depth of epidural blockade. Anesth Analg. 1998;86:341–347. doi: 10.1097/00000539-199802000-00024. [DOI] [PubMed] [Google Scholar]
  • 11.Thompson KD, Welykyj S, Massa MC. Antibacterial activity of lidocaine in combination with a bicarbonate buffer. J Dermatol Surg Oncol. 1993;19:216–220. doi: 10.1111/j.1524-4725.1993.tb00339.x. [DOI] [PubMed] [Google Scholar]
  • 12.Williams BJ, Hanke CW, Bartlett M. Antimicrobial effects of lidocaine, bicarbonate, and epinephrine. J Am Acad Dermatol. 1997;37:662–664. doi: 10.1016/s0190-9622(97)70195-6. [DOI] [PubMed] [Google Scholar]
  • 13.Sakuragi T, Ishino H, Dan K. Bactericidal activity of preservative-free bupivacaine on microorganisms in the human skin flora. Acta Anaesthesiol Scand. 1998;42:1096–1099. doi: 10.1111/j.1399-6576.1998.tb05383.x. [DOI] [PubMed] [Google Scholar]
  • 14.Goodman EJ, Jacobs MR, Bajaksouzian S. Clinically significant concentrations of local anesthetics inhibit Staphylococcus aureus in vitro. Int J Obstet Anesth. 2002;11:95–99. doi: 10.1054/ijoa.2001.0934. [DOI] [PubMed] [Google Scholar]
  • 15.Henry JB. Immunoassays and immunochemistry. In: Kasahara Y, Nakamura RM, editors. Clinical Diagnosis and Management by Laboratory Methods. 19th ed. W.B. Saunders Company; Philadelphia, Pa: 1996. pp. 851–876. [Google Scholar]
  • 16.Miller MA, Shelley WB. Antibacterial properties of lidocaine on bacteria isolated from dermal lesions. Arch Dermatol. 1985;121:1157–1159. [PubMed] [Google Scholar]

Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES